Exchange: NASDAQ·Updated 04:00 AM EDT
OLMA logo

OLMA Olema Pharmaceuticals Inc

$8.93
$0.10
(1.13%)
Pre-Market
Prev Close $8.83
EarningsNov 9
Mkt Cap$843.48M
Vol8.00

About OLMA

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
39

Bearish Sentiment

How do you feel about OLMA?

Advertisement|Remove ads.